Literature DB >> 6147010

Vasoactive intestinal polypeptide and somatostatin in leucocytes.

I Lygren, A Revhaug, P G Burhol, K E Giercksky, T G Jenssen.   

Abstract

Vasoactive intestinal polypeptide (VIP) was measured in extracts from polymorphonuclear (PMN) and mononuclear (MN) leucocytes from 14 healthy persons and 12 pigs. In addition, extracts from PMN and MN cells from eight pigs were studied for possible contents of somatostatin. Immunoreactive VIP was present in the PMN and MN leucocytes from man and pigs with a significantly higher level in the MN cells. Similarly, immunoreactive somatostatin was found in both cell lines from pigs with a significant higher amount in the MN leucocytes. Furthermore, extracts from pure populations of human PMN and MN leucocytes were separately applied on a Sephadex G-50 Fine column, and VIP, somatostatin, secretin, GIP and motilin were measured in the eluted fractions. Only VIP and somatostatin were found to be present in detectable amounts. Immunoreactive VIP eluted corresponding to the elution volume for pure porcine VIP in extracts from both PMN and MN cells, while immunoreactive somatostatin eluted corresponding to the elution volume for the synthetic tetradecapeptide somatostatin in extracts from MN cells only. Possible physiological implications of these findings are briefly discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6147010     DOI: 10.3109/00365518409083818

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  10 in total

1.  Vasoactive intestinal peptide stimulates immunoglobulin production and growth of human B cells.

Authors:  C Ishioka; A Yoshida; H Kimata; H Mikawa
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

Review 2.  Without nerves, immunology remains incomplete -in vivo veritas.

Authors:  Andrew J Shepherd; James E G Downing; Jaleel A Miyan
Journal:  Immunology       Date:  2005-10       Impact factor: 7.397

3.  Absence of vasoactive intestinal peptide expression in hematopoietic cells enhances Th1 polarization and antiviral immunity in mice.

Authors:  Jian-Ming Li; Lauren Southerland; Mohammad S Hossain; Cynthia R Giver; Ying Wang; Kasia Darlak; Wayne Harris; James Waschek; Edmund K Waller
Journal:  J Immunol       Date:  2011-06-15       Impact factor: 5.422

4.  Evidence that somatostatin is localized and synthesized in lymphoid organs.

Authors:  M C Aguila; W L Dees; W E Haensly; S M McCann
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

5.  Expression of the somatostatin gene in human astrocytoma cell lines.

Authors:  L Mercure; G S Tannenbaum; H M Schipper; D Phaneuf; M A Wainberg
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

6.  Pharmacological inhibition of VIP signaling enhances antiviral immunity and improves survival in murine cytomegalovirus-infected allogeneic bone marrow transplant recipients.

Authors:  Jian-Ming Li; Mohammad S Hossain; Lauren Southerland; Edmund K Waller
Journal:  Blood       Date:  2013-01-16       Impact factor: 22.113

7.  Lack of circadian rhythm of plasma concentrations of vasoactive intestinal peptide in patients with orthotopic heart transplants.

Authors:  P Cugini; P Lucia; G Scibilia; L Di Palma; A R Cioli; A Cianetti; L Gasbarrone; R Canova; B Marino
Journal:  Br Heart J       Date:  1993-10

8.  Neuropeptides activate human mast cell degranulation and chemokine production.

Authors:  Marianna Kulka; Cecilia H Sheen; Brian P Tancowny; Leslie C Grammer; Robert P Schleimer
Journal:  Immunology       Date:  2007-10-06       Impact factor: 7.397

9.  Vasoactive intestinal Peptide inhaled agonists: potential role in respiratory therapeutics.

Authors:  Ag Mathioudakis; V Chatzimavridou-Grigoriadou; E Evangelopoulou; Ga Mathioudakis
Journal:  Hippokratia       Date:  2013-01       Impact factor: 0.471

10.  Gastrointestinal peptides in serum and synovial fluid from patients with inflammatory joint disease.

Authors:  I Lygren; M Ostensen; P G Burhol; G Husby
Journal:  Ann Rheum Dis       Date:  1986-08       Impact factor: 19.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.